Inhalation Sciences Sweden AB (publ) develops and sells labtech equipment for inhalation research in Sweden. The company offers PreciseInhale, a laboratory system that allows scientists to measure how inhaled particles act in lungs and affect the health; DissolvIt, which enables in vitro simulation of dissolution and absorption of respirable particles in the lung epithelium; XposeALI, a 3D cell exposure module that combines aerosol capability with 3D cell models cultured at an air liquid interface; Nose-only inhalation, a standard method of exposure used in preclinical testing of inhalation drugs, as well as for inhalation toxicity studies in rodents; and intratracheal exposure module, an unique technology delivering aerosol directly to the lungs, bypassing the nose, and to spontaneously breathing rodents. Inhalation Sciences Sweden AB (publ) was incorporated in 2004 and is based in Huddinge, Sweden.
Name | Title | Since | Age |
|---|---|---|---|
| Jan Hellqvist | Chairman of the board | 2025 | 61 |
| Per Gerde | Chief Scientific Officer & Director | - | 73 |
| Gary Pitcairn | Member of Advisory Board | - | 59 |
| Martin Wehling | Member of Advisory Board | - | - |
| Magnus Svartengren | Member of Advisory Board | - | - |
| Carsten Ehrhardt | Member of Advisory Board | - | - |
| Per Wollmer | Member of Advisory Board | - | - |
| Ulf Ericsson | Director | 2024 | - |
| Niklas Lindecrantz | Director | 2025 | 58 |